Cargando…
A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722275/ https://www.ncbi.nlm.nih.gov/pubmed/34980153 http://dx.doi.org/10.1186/s12943-021-01483-8 |
| _version_ | 1784625494072754176 |
|---|---|
| author | Lee, In-Seob Zhu, Zhongxu Lee, Jeeyun Park, Joon Oh Wu, Xiwei Ong, Tiffany Li, Sierra Min Wang, Xin Chao, Joseph Goel, Ajay |
| author_facet | Lee, In-Seob Zhu, Zhongxu Lee, Jeeyun Park, Joon Oh Wu, Xiwei Ong, Tiffany Li, Sierra Min Wang, Xin Chao, Joseph Goel, Ajay |
| author_sort | Lee, In-Seob |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8722275 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87222752022-01-06 A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology Lee, In-Seob Zhu, Zhongxu Lee, Jeeyun Park, Joon Oh Wu, Xiwei Ong, Tiffany Li, Sierra Min Wang, Xin Chao, Joseph Goel, Ajay Mol Cancer Letter to the Editor BioMed Central 2022-01-03 /pmc/articles/PMC8722275/ /pubmed/34980153 http://dx.doi.org/10.1186/s12943-021-01483-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Lee, In-Seob Zhu, Zhongxu Lee, Jeeyun Park, Joon Oh Wu, Xiwei Ong, Tiffany Li, Sierra Min Wang, Xin Chao, Joseph Goel, Ajay A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology |
| title | A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology |
| title_full | A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology |
| title_fullStr | A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology |
| title_full_unstemmed | A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology |
| title_short | A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology |
| title_sort | liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722275/ https://www.ncbi.nlm.nih.gov/pubmed/34980153 http://dx.doi.org/10.1186/s12943-021-01483-8 |
| work_keys_str_mv | AT leeinseob aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT zhuzhongxu aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT leejeeyun aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT parkjoonoh aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT wuxiwei aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT ongtiffany aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT lisierramin aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT wangxin aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT chaojoseph aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT goelajay aliquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT leeinseob liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT zhuzhongxu liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT leejeeyun liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT parkjoonoh liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT wuxiwei liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT ongtiffany liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT lisierramin liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT wangxin liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT chaojoseph liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology AT goelajay liquidbiopsysignaturepredictstreatmentresponsetofluoropyrimidineplusplatinumtherapyinpatientswithmetastaticorunresectablegastriccancerimplicationsforprecisiononcology |